Veracyte, Inc.
VCYT
$46.32
-22.52%
VCYT price trend
Wall Street consensus
Most Wall Street analysts maintain a constructive view on Veracyte, Inc.'s 12-month outlook, with a consensus price target around $56.55 and implied upside of +22.1% versus the current price.
Average Target
$56.55
0 analysts
Implied Upside
+22.1%
vs. current price
Analyst Count
—
covering this stock
Price Range
$45 - $70
Analyst target range
VCYT Technical Analysis
Beta
—
—
Max Drawdown
-39.2%
Largest decline past year
52-Week Range
$23-$61
Price range past year
Annual Return
+97.0%
Cumulative gain past year
| Period | VCYT Return | S&P 500 |
|---|---|---|
| 1m | -22.6% | +0.2% |
| 3m | +40.0% | +3.7% |
| 6m | +21.6% | +8.0% |
| 1y | +97.0% | +18.2% |
| ytd | +9.3% | +9.6% |
Bobby - Your AI Investment Partner
Get real-time data, AI-driven personalized investment analysis to make smarter investment decisions
Valuation Analysis: Is VCYT Overvalued?
PE
50.1x
Latest Quarter
vs. Historical
N/A
5-Year PE Range 17x~59x
vs. Industry Avg
N/A
Industry PE ~N/A*
EV/EBITDA
33.3x
Enterprise Value Multiple